Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker VERA
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | Marshall Fordyce Director, Officer | VERA Vera Therapeutics, Inc. | 64,750 | $2.2M | 10b5-1 | Sep 2, 2026 | Form 4 ↗ 2 days later · 18,500 shares | Form 144 ↗ |
| Jun 23, 2026 | Marshall Fordyce Director, Officer | VERA Vera Therapeutics, Inc. | 74,000 | $2.8M | 10b5-1 | Jun 23, 2026 | Form 4 ↗ 1 day later · 18,500 shares | Form 144 ↗ |
| May 12, 2026 | Marshall Fordyce Director, Officer | VERA Vera Therapeutics, Inc. | 18,500 | $677.3K | 10b5-1 | May 12, 2026 | Form 4 ↗ 1 day later · 18,500 shares | Form 144 ↗ |
| Apr 14, 2026 | Marshall Fordyce Director, Officer | VERA Vera Therapeutics, Inc. | 22,951 | $1.0M | 10b5-1 | Apr 14, 2026 | Form 4 ↗ 1 day later · 22,951 shares | Form 144 ↗ |
| Feb 23, 2026 | Laurence Skelton Officer | VERA Vera Therapeutics, Inc. | 1,800 | $75.7K | — | Feb 23, 2026 | Form 4 ↗ 2 days later · 1,582 shares | Form 144 ↗ |
| Feb 23, 2026 | William Donald Turner Officer | VERA Vera Therapeutics, Inc. | 2,600 | $109.3K | — | Feb 23, 2026 | Form 4 ↗ 2 days later · 2,187 shares | Form 144 ↗ |
| Feb 23, 2026 | Sean Grant Officer | VERA Vera Therapeutics, Inc. | 5,700 | $239.6K | — | Feb 23, 2026 | Form 4 ↗ 2 days later · 4,949 shares | Form 144 ↗ |
| Feb 23, 2026 | Robert Brenner Officer | VERA Vera Therapeutics, Inc. | 2,500 | $105.1K | — | Feb 23, 2026 | Form 4 ↗ 2 days later · 2,151 shares | Form 144 ↗ |
| Feb 23, 2026 | David L Johnson Officer | VERA Vera Therapeutics, Inc. | 2,900 | $121.9K | — | Feb 23, 2026 | Form 4 ↗ 2 days later · 2,579 shares | Form 144 ↗ |
| Feb 23, 2026 | Marshall Fordyce Officer | VERA Vera Therapeutics, Inc. | 16,600 | $697.8K | — | Feb 23, 2026 | Form 4 ↗ 2 days later · 16,925 shares | Form 144 ↗ |
| Dec 15, 2025 | William Turner Officer | VERA Vera Therapeutics, Inc. | 10,000 | $498.0K | 10b5-1 | Dec 15, 2025 | Form 4 ↗ 2 days later · 10,000 shares | Form 144 ↗ |
| Dec 8, 2025 | William Turner Officer | VERA Vera Therapeutics, Inc. | 10,000 | $449.0K | 10b5-1 | Dec 8, 2025 | Form 4 ↗ 2 days later · 10,000 shares | Form 144 ↗ |
| Dec 3, 2025 | William Turner Officer | VERA Vera Therapeutics, Inc. | 10,000 | $372.5K | 10b5-1 | Dec 3, 2025 | Form 4 ↗ 1 day later · 10,000 shares | Form 144 ↗ |
| Nov 24, 2025 | Jason S. Carter Officer | VERA Vera Therapeutics, Inc. | 3,864 | $107.7K | — | Nov 21, 2025 | Form 4 ↗ 1 day later · 3,864 shares | Form 144 ↗ |
| Feb 26, 2025 | Marshall Fordyce Director, Officer | VERA Vera Therapeutics, Inc. | 9,075 | $245.9K | 10b5-1 | Feb 26, 2025 | Form 4 ↗ 1 day later · 9,075 shares | Form 144 ↗ |
| Jan 8, 2025 | Marshall Fordyce Director, Officer | VERA Vera Therapeutics, Inc. | 17,500 | $736.8K | 10b5-1 | Jan 8, 2025 | Form 4 ↗ 2 days later · 17,500 shares | Form 144 ↗ |
| Dec 18, 2024 | Marshall Fordyce Director, Officer | VERA Vera Therapeutics, Inc. | 17,500 | $768.4K | 10b5-1 | Dec 18, 2024 | Form 4 ↗ 2 days later · 17,500 shares | Form 144 ↗ |
| Dec 11, 2024 | Marshall Fordyce Director, Officer | VERA Vera Therapeutics, Inc. | 17,500 | $821.1K | 10b5-1 | Dec 11, 2024 | Form 4 ↗ 2 days later · 17,500 shares | Form 144 ↗ |
| Nov 25, 2024 | Marshall Fordyce Director, Officer | VERA Vera Therapeutics, Inc. | 19,375 | $936.0K | 10b5-1 | Nov 25, 2024 | Form 4 ↗ 2 days later · 19,375 shares | Form 144 ↗ |
| Nov 13, 2024 | Marshall Fordyce Director, Officer | VERA Vera Therapeutics, Inc. | 30,625 | $1.5M | 10b5-1 | Nov 13, 2024 | Form 4 ↗ 2 days later · 30,625 shares | Form 144 ↗ |
| Oct 28, 2024 | Beth C Seidenberg Director | VERA Vera Therapeutics, Inc. | 15,000 | $616.4K | 10b5-1 | Oct 28, 2024 | Form 4 ↗ 2 days later · 15,000 shares | Form 144 ↗ |
| Oct 23, 2024 | Marshall Fordyce Director, Officer | VERA Vera Therapeutics, Inc. | 19,375 | $788.8K | 10b5-1 | Oct 23, 2024 | Form 4 ↗ 2 days later · 19,375 shares | Form 144 ↗ |
| Oct 9, 2024 | Marshall Fordyce Director, Officer | VERA Vera Therapeutics, Inc. | 15,625 | $603.8K | 10b5-1 | Oct 9, 2024 | Form 4 ↗ 2 days later · 15,625 shares | Form 144 ↗ |
| Sep 25, 2024 | Marshall Fordyce Director, Officer | VERA Vera Therapeutics, Inc. | 7,500 | $350.3K | 10b5-1 | Sep 25, 2024 | Form 4 ↗ 16 days later · 15,625 shares | Form 144 ↗ |
| Sep 18, 2024 | Beth C Seidenberg Director | VERA Vera Therapeutics, Inc. | 15,000 | $600.3K | 10b5-1 | Sep 18, 2024 | Form 4 ↗ 42 days later · 15,000 shares | Form 144 ↗ |
| Sep 18, 2024 | Samuel B Seidenberg Irrev Trust U/A DTD 07/01/2013 Director | VERA Vera Therapeutics, Inc. | 1,476 | $59.1K | 10b5-1 | Sep 18, 2024 | Form 4 ↗ 42 days later · 15,000 shares | Form 144 ↗ |
| Sep 11, 2024 | Marshall Fordyce Director, Officer | VERA Vera Therapeutics, Inc. | 31,250 | $1.2M | 10b5-1 | Sep 11, 2024 | Form 4 ↗ 30 days later · 15,625 shares | Form 144 ↗ |
| Aug 28, 2024 | Marshall Fordyce Director, Officer | VERA Vera Therapeutics, Inc. | 30,320 | $1.1M | 10b5-1 | Aug 28, 2024 | Form 4 ↗ 44 days later · 15,625 shares | Form 144 ↗ |
| Aug 14, 2024 | Marshall Fordyce Director, Officer | VERA Vera Therapeutics, Inc. | 15,625 | $593.0K | 10b5-1 | Aug 14, 2024 | Form 4 ↗ 58 days later · 15,625 shares | Form 144 ↗ |
| Apr 3, 2024 | Grant Sean Officer | VERA Vera Therapeutics, Inc. | 118,477 | $4.7M | — | Apr 3, 2024 | — | Form 144 ↗ |
| Mar 21, 2024 | Katabi Maha Director | VERA Vera Therapeutics, Inc. | 850,000 | $38.5M | — | Mar 21, 2024 | — | Form 144 ↗ |
| Jan 29, 2024 | Celia JF Lin Officer | VERA Vera Therapeutics, Inc. | 219,277 | $7.3M | — | Jan 29, 2024 | — | Form 144 ↗ |
32 items, most recent first (up to 50). Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 8:04 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances